133 related articles for article (PubMed ID: 30611566)
1. Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapy.
Singh B; Singh G; Alzahrani N; Arrowaili A; Morris DL
Eur J Surg Oncol; 2019 Apr; 45(4):620-624. PubMed ID: 30611566
[TBL] [Abstract][Full Text] [Related]
2. Long-term Survival and Propensity Score Matched Outcomes of Bilateral
Singh B; Singh G; Pourgholami M; Alzahrani N; Morris DL
Anticancer Res; 2018 Oct; 38(10):5917-5921. PubMed ID: 30275219
[TBL] [Abstract][Full Text] [Related]
3. Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery + intra-peritoneal chemotherapy.
Singh B; Singh G; Alzahrani N; Morris DL
Am J Surg; 2020 Apr; 219(4):673-680. PubMed ID: 31255258
[TBL] [Abstract][Full Text] [Related]
4. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
5. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
Dhir M; Ramalingam L; Shuai Y; Pakrafter S; Jones HL; Hogg ME; Zureikat AH; Holtzman MP; Ahrendt SA; Bahary N; Pingpank JF; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2017 Apr; 24(4):875-883. PubMed ID: 27995449
[TBL] [Abstract][Full Text] [Related]
7. Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement.
Franssen B; Tabrizian P; Weinberg A; Romanoff A; Tuvin D; Labow D; Sarpel U
Ann Surg Oncol; 2015 May; 22(5):1639-44. PubMed ID: 25216604
[TBL] [Abstract][Full Text] [Related]
8. Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies.
Choudry MHA; Shuai Y; Jones HL; Pai RK; Pingpank JF; Ahrendt SS; Holtzman MP; Zeh HJ; Bartlett DL
Ann Surg Oncol; 2018 Dec; 25(13):3950-3959. PubMed ID: 30302637
[TBL] [Abstract][Full Text] [Related]
9. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
Kyang LS; Alzahrani NA; Valle SJ; Rahman MK; Arrowaili A; Liauw W; Morris DL
J Surg Oncol; 2019 Sep; 120(4):794-802. PubMed ID: 31309588
[TBL] [Abstract][Full Text] [Related]
11. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
Wong JF; Tan GH; Wang W; Soo KC; Teo MC
World J Surg; 2015 Jun; 39(6):1578-83. PubMed ID: 25651962
[TBL] [Abstract][Full Text] [Related]
12. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Teo MC; Tan GH; Tham CK; Lim C; Soo KC
Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
[TBL] [Abstract][Full Text] [Related]
14. Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Lyon TD; Turner Ii RM; Nikonow TN; Wang L; Uy J; Ramalingam L; Holtzman MP; Pingpank JF; Bartlett DL; Davies BJ
J Surg Oncol; 2016 Feb; 113(2):218-22. PubMed ID: 26775909
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
Chouliaras K; Levine EA; Fino N; Shen P; Votanopoulos KI
Ann Surg Oncol; 2017 Apr; 24(4):890-897. PubMed ID: 27995450
[TBL] [Abstract][Full Text] [Related]
17. Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Devilee RA; Simkens GA; van Oudheusden TR; Rutten HJ; Creemers GJ; Ten Tije AJ; de Hingh IH
Ann Surg Oncol; 2016 Sep; 23(9):2841-8. PubMed ID: 27044447
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours.
Sarkar A; Lansom J; Dey A; Fisher O; Alzahrani N; Morris DL
Eur J Surg Oncol; 2021 Jun; 47(6):1406-1410. PubMed ID: 33279358
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.
Mercier F; Bakrin N; Bartlett DL; Goere D; Quenet F; Dumont F; Heyd B; Abboud K; Marolho C; Villeneuve L; Glehen O; ;
Ann Surg Oncol; 2018 Jun; 25(6):1668-1675. PubMed ID: 29637438
[TBL] [Abstract][Full Text] [Related]
20. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]